Makovsky applies our expertise in evidence-based storytelling to biopharma, biotech, medtech, and life sciences companies that transform the well-being of patients. We are facile with exciting and disruptive technologies, as well as emerging therapies that solve the most challenging, unmet patient needs, including rare diseases.
We provide our clients with sophisticated investor / financial communications, media, integrated multichannel and PR marketing capabilities, along with digital influencer engagement to amplify your story, ensuring your innovations in emerging therapeutics are noticed by the most relevant audiences.
Makovsky’s life sciences and capital markets advisors partner with biotech, medtech and healthcare companies at any stage of their development, from seed stage teams to mature publicly traded companies. We also work with venture capital and private equity investors and investment banks in the life sciences areas.
At Makovsky, we are committed to our client’s success and delivering standout service is at the center of that. Below is a quick and easy way to get in touch with one of our communications experts. Just fill out the form and the nature of your inquiry and we will respond as soon as possible. Alternatively you can reach us directly at 212.508.9600